Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Mar 2;252(3):259–267. doi: 10.1016/j.taap.2011.02.017

Table 1. Comparison of CYP expression between WT and PXR-null mice.

CYP WT Female PXR-null Female WT Male PXR-null Male
Cyp2b9 14.97 ± 4.96 a** 6.47 ± 1.27 1.00 ± 0.81 0.69 ± 0.46
Cyp2b10 2.42 ± 0.53 23.64 ± 5.53 b** 1.00 ± 0.41 6.74 ± 2.28 d**
Cyp2c29 0.82 ± 0.28 1.42 ± 0.85 1.00 ± 0.28 1.87 ± 0.44
Cyp3a11 1.19 ± 0.24 0.31 ± 0.06 b* 1.00 ± 0.24 0.26 ± 0.08c*
Cyp3a41 60.98 ± 15.31 a* 125.37 ± 23.26 b* 1.00 ± 0.76 0.85 ± 0.31d**

Data is expressed as relative data ± SEM

*

P-value < 0.05 and

**

p-value < 0.01; indicate statistical significance by one-way ANOVA followed by Dunnett's multiple comparison test.

a

Indicates significant difference between WT female and WT male.

b

Indicates significant difference between WT female and PXR-null female mice.

c

Indicates significant difference between WT male and PXR-null male mice.

d

Indicates significant difference between PXR-null female and PXR-null male mice.